# Intravenous Oxytocin Versus Tranexamic Acid in Reducing Blood Loss During Abdominal Myomectomy.

> **NCT03892668** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 150 (actual)

## Conditions studied

- Myomectomy

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** oxytocin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03892668
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-30
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-03-15
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03892668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03892668, "Intravenous Oxytocin Versus Tranexamic Acid in Reducing Blood Loss During Abdominal Myomectomy.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03892668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*